Regenerative medicine in society: Interdisciplinary perspectives
FSG Connect, an imprint of Future Science Group (FSG), is excited to announce the launch of three Apps for Apple and Android with the aim of giving time-pressed medical and science professionals the content they need both on-the-go and in an accessible format.
Launched in September, the Bioanalysis Zone, Oncology Central and Neurology Central Apps are free to download and access, and provide users with personalized content published on related websites over the previous 30 days.
Providing news, journal articles and video content, the Apps are the ideal way in which to stay up-to-date with these fast moving fields when the user is on their morning commute, lunch break or before bed.
Rosalind Hill, Digital Publishing Director at FSG, said: 'Access to information digitally, at the touch of a button and on demand has never been so important, and especially for those working in the medical and scientific industries. These subject areas are fast-moving, fast-evolving and at the forefront of research, so being able to provide users with the content they need – from anywhere – is a great privilege.'
The Apps will be developed even further over the coming months with social media integrations and bookmarking tools, for example.
Existing subscribers to Bioanalysis Zone, Oncology Central or Neurology Central will be able to sign in to the Apps with their existing user accounts.
Download Bioanalysis Zone App: https://www.bioanalysis-zone.com/mobile-app/
Download Oncology Central App: https://www.oncology-central.com/mobile-app/
Download Neurology Central App: https://www.neurology-central.com/mobile-app/
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.futuresciencegroup.com